Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Novel MPZ Gene Mutation in Exon 2 Causing Late-Onset Demyelinating Charcot-Marie-Tooth Disease.
Magnetic susceptibility and isothermal remanent magnetization in human tissues: a study case.
Microglia Plasticity During Health and Disease: An Immunological Perspective.
Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.
Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.
The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
SOX2+ Cell Population from Normal Human Brain White Matter Is Able to Generate Mature Oligodendrocytes.
Assessing humoral immunocompetence after alemtuzumab treatment in MS.
Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis.
Acute demyelinating encephalomyelitis presenting with psychiatric symptoms.
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal.
Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6.
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
Direction-specific impairments of limits of stability in individuals with multiple sclerosis.
IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression.
The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.
Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients.
[Effective rehabilitation of hospitalized patients with multiple sclerosis].
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis.
Involvement of membrane skeletal molecules in the Schmidt-Lanterman incisure in Schwann cells.
Dentatorubrothalamic tract localization with postmortem MR diffusion tractography compared to histological 3D reconstruction.
[Anti-neurofascin antibody in combined central and peripheral demyelination].
Pages
« first
‹ previous
…
678
679
680
681
682
683
684
685
686
…
next ›
last »